Abstract:The ligand 2-['2-(4,5-dimethyl thiazolyl)azo]-imidazole (DMeTAI), which is generated from 2-amino-4,5-dimethylthiazol and imidazole, was used to synthesize coordination compounds containing Ni(II) and Cu(II) ions. To confirm the structure of the synthesized chelates, a range of analytical techniques were used, including thermal analysis, X-ray powder diffraction, infrared spectroscopy, mass spectrometry, magnetic susceptibility analysis, microanalysis, and 1 H NMR. The complexes have the formula [M(L) 2 ]Cl 2 .H 2 O, where M stands for Ni(II) or Cu(II), and the results showed that the metal ion–ligand ratio was 1:2. Molar conductivity results demonstrated that the complexes are all electrolytes that fall within a certain range 77.01–83.56 Ω −1 cm 2 mol −1 , and the magnetic susceptibility measurements indicated an octahedral structural geometry for the complexes. Besides, the central metal ion interacts with the ligand as a tridentate (N,N,N) coordination by the (C=N) nitrogen atom from the thiazole moiety, the (N=N) nitrogen atom from the azo group, and the (C=N) nitrogen atom from the imidazole moiety. Thermal analysis (TG/DTG) showed that the thermal decomposition of the obtained compounds is a multi-stage process depending on the metal ion and atmosphere in which was conducted. Computational methods were subsequently utilized to delve more deeply into the properties of both the ligand and metallic complexes. The structural formulas of the examined azo dye ligand and metal complexes were optimized using the Gaussian09 program. Additionally, the DFT/B3LYP method was employed to compute energy gaps and other pertinent theoretical parameters. Molecular docking using the MOE 2015 program was utilized to explore the interactions of the compounds with the human p110alpha/p85alpha complex (PDB ID: 2RD0), which is associated with ovarian carcinoma. We determined the energies of hydrophobic and hydrogen bonding from the analysis of the docked protein receptors. In addition to the theoretical investigations, both the ligand and metallic complexes were evaluated for their effectiveness as antibacterial agents against Staphylococcus aureus (Gram-positive), Escherichia coli (Gram-negative), and the antifungal strain Penicillium sp. The findings revealed that the ligand and its metallic complexes demonstrated moderate antimicrobial efficacy against both Gram-positive and Gram-negative microbes, surpassing the standard drugs Ciprofloxacin and Cycloheximide. Additionally, the cytotoxicity of the ligand was assessed against human ovarian carcinoma cancer cells (SKOV-3). Furthermore, in silico ADMET analysis predicted favourable pharmacokinetic and toxicity profiles for the synthesized molecules, indicating promising oral drug-like properties and a nontoxic nature.

An efficient synthesis for Cd(II), Cu(II), and UO 2 (II) complexes with N-ethyl-2-(1-(naphthalen-1-yl)ethylidene)hydrazine-1-carbothioamide under solvent-free condition using ball milling as green protocol

Green processing and characterization of Novel HETERO-ligand Co(II) complexes with cyanopyridine derivatives: Quantitative structure, Computational assessment, and Biological activity relationship

Green and Efficient Synthesis, Spectroscopic, Characterization, Antibacterial Activity of Some Selected Transition Metal Complexes of Novel Schiff Base Ligand Derived from 2-amino 5-methyl benzimidazole with 2-bromo Isophthalaldehyde

Synthesis, and characterization of Ni(II), and Cu(II) metal complexes containing new azo dye ligand (N,N,N) and evaluation of their biological activities supported by DFT studies, molecular docking, ADMET profiling, drug-likeness analysis and toxicity prediction

Green synthesis of nanosized N,N'-bis(1-naphthylidene)-4,4'-diaminodiphenylmethane and its metal (II) complexes and evaluation of their biological activity

Synthesis, structural characterization, antioxidant, cytotoxic activities and docking studies of schiff base Cu(II) complexes

Synthesis and Characterization for New Nanometer Cu(II) Complexes, Conformational Study and Molecular Docking Approach Compatible with Promising in Vitro Screening

Synthesis, Spectral Characterization, Antimicrobial Activity, DFT Calculations, Molecular Docking and ADME Studies of Novel Schiff Base Co(II), Ni(II), Cu(II) and Zn(II) Complexes Derived from 4‐nitro‐ortho‐phenylenediamine

Synthesis, Spectroscopic, Computational Structure Analysis, Molecular Docking, in vitro Antibacterial and in vivo Antipyretic Investigations of Transition Metal(II) Complexes

Design, Spectroscopic Analysis, DFT Calculations, Catalytic Evaluation, and Comprehensive In Silico and In Vitro Bioactivity Studies, Including Molecular Docking, of Novel Co(II) Complexes of 2-Hydroxy-5,3-(phenylallylidene)aminobenzoic Acid

SYNTHESIS, CHARACTRIZATION AND ANTIBACTERIAL ACTIVITY OF SCHIFF BASES DERIVED FROM PHENYL HYDRAZINE DERIVATIVES AND THEIR Cu (II) and Zn (II) COMPLEXES

Preparation, Characterization, DFT Calculations, Antibacterial and Molecular Docking Study of Co(II), Cu(II), and Zn(II) Mixed Ligand Complexes

N′-(Furan-2-ylmethylene)-2-hydroxybenzohydrazide and its metal complexes: synthesis, spectroscopic investigations, DFT calculations and cytotoxicity profiling

Synthesis and Structural Elucidation for New Schiff Base Complexes; Conductance, Conformational, MOE-Docking and Biological Studies

Synthesis, Structural Determination, DFT Calculation and Biological Evaluation Supported by Molecular Docking Approach of Some New Complexes Incorporating (E)‐N'‐(3,5‐di‐Tert‐Butyl‐2‐Hydroxybenzylidene) Isonicotino Hydrazide Ligand

Synthesis, structural analysis, in vitro antioxidant, antimicrobial activity and molecular docking studies of transition metal complexes derived from Schiff base ligands of 4-(benzyloxy)-2-hydroxybenzaldehyde

Synthesis, structure elucidation, antioxidant, antimicrobial, anti-inflammatory and molecular docking studies of transition metal(II) complexes derived from heterocyclic Schiff base ligands

Synthesis, structural characterization, in vitro biological activity, and DFT calculations of Cu(II) complex

Synthesis, characterization, biological potency, and molecular docking of Co2+, Ni2+ and Cu2+ complexes of a benzoyl isothiocyanate based ligand

Three Co(II), Ni(II) and Cu(II) Schiff base complexes incorporating 2-[(4-{[(4-methylphenyl)sulfonothioyl]oxy}phenyl)methylene] amino}benzoic acid: Synthesis, structural, dft, biological and molecular docking investigation

Synthesis, Structural Characterization, Optical Properties, and Biological Potency of Co(II), Cu(II), and Cd(II) Complexes With Heterocyclic Thiosemicarbazide Ligand: Insights From Molecular Docking Studies